Key facts
- Grenova’s last known valuation is $3.5M (Sep 2018).
- It has raised $650K across 1 recorded rounds; the latest was Seed Round ($550K) in Aug 2018.
- Notable investors include Morgan Stanley, Hamilton Lane, Peloton Equity, Stonehaven Capital.
- Grenova has filed 2 Form Ds with the SEC since 2018, most recently Aug 2019 ($100K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Grenova
Funding rounds
1 roundsAbout Grenova
Manufacturer of lab consumables intended to lower costs in clinical labs, pharmaceutical, biotech companies, research institutions, and agricultural companies. The company develops devices that enable customers to wash contaminated pipette tips in large quantities for reuse, thereby reducing biohazard waste in the environment and making labs sustainable, efficient, and resilient to supply chain disruptions.
- Sector
- Information Technology
- HQ
- Richmond, VA, United States
- Employees
- 39
- Website
- grenova.com/
- Ownership
- Privately Held (backing)
Grenova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Grenova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Grenova in its N-PORT filings yet. We sweep new filings monthly.